Electrophysiology and Arrhythmias

Science News

2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke
Establishment of Specialized Clinical Cardiovascular Genetics Programs Recognizing Standards
Device Therapy and Arrhythmia Management in Left Ventricular Assist Device Recipients
2019 CVD Primary Prevention Guideline
AHA/ACC Special Report: Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease (ASCVD)

Continuing Education

Scientific Sessions attendees looking at a phone in front of giant Heart and Torch stature

Meet us in November in Boston or online from anywhere through our virtual platform for the global cardiovascular event of the year! Reconnect with colleagues, experience breakthrough cardiovascular basic, clinical and population science updates, and immerse yourself in innovative solutions designed to help you in your daily practice at the American Heart Association’s Scientific Sessions 2021.

  • Enjoy instant access to leaders in the field and the latest discoveries in cardiovascular science and medicine.

  • Reconnect and collaborate with global thought leaders from over around the world.

  • Experience programming designed with your needs in mind with 27 programming communities.
  • CE and MOC credits available.

  • And more!

Don’t forget! AHA Professional Members receive the best rates for attending Scientific Sessions. Learn more about this and other benefits by becoming an AHA Professional Member.

The CLCD Council supports AHA objectives in clinical cardiology, promotes excellent clinical care, and fosters professional development and education for clinical cardiologists. Through council-sponsored symposia, panels, and scientific conferences, members can access and interpret new developments in the field and promote clinical cardiology to professional and lay audiences.


CRAVE Results

Gregory M. Marcus, MD, MAS explains the methodology and results of the CRAVE trial, designed to assess the acute affects of coffee consumption in ambulatory patients.

aMAZE Results

Mina Chung, MD, FHRS discusses the results of the aMAZE trial with principal investigator David J. Wilber, MD, FAHA, FACC, FHRS. The trial examined percutaneous alternatives to the MAZE procedure for persistent AF.

American Heart Association Professional Members

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses